Sundial Growers Inc.
SNDL • NASDAQ
Sundial Growers Inc. is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Zachary Ryan George, with a market cap of $339.6M.
CEOZachary Ryan George
Next Earnings
Upcoming earnings announcement for Sundial Growers Inc.
Date
Thursday, April 30, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.04
Revenue Estimate
$187.5M
Earnings History
Past 12 earnings reports for Sundial Growers Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 12, 2026 | Q4 2025 | $0.04Est: $0.01 | +300.0% | $252.5MEst: $228.1M | +10.7% | — |
| Nov 4, 2025 | Q3 2025 | -$0.05Est: -$0.02 | -150.0% | $244.2MEst: $216.5M | +12.8% | — |
| Jul 31, 2025 | Q2 2025 | $0.01Est: -$0.04 | +125.0% | $244.8MEst: $205.6M | +19.1% | — |
| May 1, 2025 | Q1 2025 | -$0.06Est: -$0.06 | 0.0% | $204.9MEst: $149.9M | +36.7% | — |
| Mar 18, 2025 | Q4 2024 | -$0.19 | — | $257.7M | — | — |
| Nov 5, 2024 | Q3 2024 | -$0.07Est: -$0.04 | -75.0% | $236.9MEst: $167.0M | +41.9% | — |
| Aug 1, 2024 | Q2 2024 | -$0.02 | — | $228.1MEst: $176.4M | +29.3% | — |
| May 9, 2024 | Q1 2024 | -$0.01Est: -$0.04 | +75.0% | $197.8MEst: $154.9M | +27.7% | — |
| Mar 21, 2024 | Q4 2023 | -$0.32 | — | $248.5M | — | — |
| Nov 13, 2023 | Q3 2023 | -$0.08 | — | $237.6M | — | — |
| Aug 14, 2023 | Q2 2023 | -$0.12 | — | $244.5M | — | — |
| May 15, 2023 | Q1 2023 | -$0.14 | — | $202.5M | — | — |